← Back to Clinical Trials
Recruiting NCT06819969

NCT06819969 The Canadian Lung Outcomes in Users of Vaping Devices Study

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06819969
Status Recruiting
Phase
Sponsor University of British Columbia
Condition Small Airways Diseases
Study Type OBSERVATIONAL
Enrollment 500 participants
Start Date 2025-07-25
Primary Completion 2029-12-31

Trial Parameters

Condition Small Airways Diseases
Sponsor University of British Columbia
Study Type OBSERVATIONAL
Phase N/A
Enrollment 500
Sex ALL
Min Age 12 Years
Max Age N/A
Start Date 2025-07-25
Completion 2029-12-31

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Vaping is increasingly popular with both adolescent and adult Canadians, but the long-term health impacts remain unknown. We believe that the tools we currently have to detect lung disease in people who vape may be insufficient and propose new ways to find lung injuries that may impact them over the course of their lives. These include exercise testing, new imaging techniques, and new breathing tests that will demonstrate how vaping may harm their lungs. We will use these tools in both adolescent and adult Canadians to give Canadians who vape important information on the consequences of vaping.

Eligibility Criteria

Inclusion Criteria: Adolescent arm: * Aged ≥12 and \<19 years old * Either 1) use neither combustible cigarettes nor e-cigarettes or 2) use e-cigarettes exclusively Adult arm: * Aged ≥19 years old * Fall into one of the following categories: 1) use neither combustible cigarettes nor e-cigarettes; 2) use combustible cigarettes exclusively, never using e-cigarettes; 3) use e-cigarettes exclusively, never using combustible cigarettes; or 4) use both combustible cigarettes and e-cigarettes currently Exclusion Criteria: Adolescent arm: * Contraindication to pulmonary function testing and cardiopulmonary exercise testing * Have smoked combustible cannabis within the last month and/or have a combustible cannabis smoking history of \>1 joint-year * Have smoked combustible cigarettes within the last 6 months * Have a physician-diagnosed chronic lung disease (such as asthma, cystic fibrosis, or bronchopulmonary dysplasia) * Inability to provide written informed consent Adult arm: * Contraindicat

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology